Spinal afferent neurons are of particular interest because, in contrast to vagal afferents, they play the major role in detection and transduction of painful stimuli from internal (visceral) organs. Recently, there have been major technical advances in our ability to understand the innervation of spinal afferent endings in visceral organs. Although it is well known that the sensory neurons of spinal afferents reside within dorsal root ganglia (DRG), identifying the nerve endings of spinal afferents in internal organs has been more challenging. This has been due, largely, to a lack of techniques to selectively label spinal afferents. To get around this problem, we recently developed a surgical technique in live mice that allows selective labelling of only spinal afferent axons and their endings. This approach revealed an unexpectedly complex and diverse array of different types of varicose and non-varicose spinal afferent endings in visceral organs, particularly the large intestine. In total, 13 different types of endings were identified in the terminal large intestine, originating from lumbosacral DRGs. The stomach, esophagus, bladder and uterus had noticeably less diversity and density of spinal afferent endings compared with the distal large bowel. Taken together, compared to vagal afferent endings, spinal afferent endings (at least in the large intestine) show greater morphological diversity and complexity. We discuss new insights into the innervation of spinal afferent endings in visceral organs and the advantages of surgically exposing DRGs in live mice.
INTRODUCTION
In vertebrates, the ability to perceive painful stimuli is an evolutionary adaptation to prevent injury or death. Some humans are born with a complete inability to detect any pain (7) and whilst these people can live a normal life span, they often unconsciously inflict harm (sometimes lethal) on their bodies. Painful stimuli are normally detected by nociceptors, whose transduction sites respond to potentially damaging (painful) stimuli, by sending action potentials to the spinal cord and brain, a process broadly referred to as nociception. Deficits in specific classes of spinal afferents can lead to substantially reduced nociception from visceral organs (38). Therefore, understanding the characteristics of the different types of spinal afferent endings in the visceral organs can provide us with valuable new clues regarding nociception.
There is clear evidence in mammals, that most, if not all painful stimuli arising from internal organs are detected by spinal afferent neurons, whose cell bodies lie in DRG (12, 38) . This was determined largely by lesion studies to the vagus nerve which failed to block painful sensations, whereas lesions to the spinal cord abolished all visceral sensation (12) , including those of a noxious origin (12) . Despite our understanding of the location of the cell bodies of spinal afferent neurons within DRG (12, 33), one major unresolved mystery is the location of the nerve endings of spinal afferents that actually convert noxious stimuli into nerve action potentials, that are ultimately relayed to the CNS (4, 36). The major reason why it has been so difficult to identify the location of spinal afferent endings in visceral organs is because, unlike vagal afferent neurons, which are readily accessible for injection of neuronal tracers during surgery, DRG are not easily accessed surgically in live animals, particularly in small laboratory animals. Identifying spinal afferent nerve endings in the gastrointestinal (GI) tract has the added complication that the wall of the GI-tract has its own completely independent nervous system, known as the enteric nervous system (3, 8, 26 ) and many of the neurochemical markers that are expressed in DRG (and hence are present in spinal afferent nerve endings within the gut wall) are also expressed in enteric neurons; such as substance P (5, 6) and calcitonin gene related peptide (CGRP) (9) .
Because a significant proportion of spinal afferent endings ramify within the enteric nervous system (ENS) (14, 30) , attempts to disentangle the nerve endings of spinal afferents from enteric nerve axons, or other extrinsic autonomic nerve axons has proved effectively impossible, when using antibodies alone.
Anatomical features of spinal afferents and other sensory neurons
Spinal afferents are not the only sensory neurons in vertebrates. A number of cranial nerves are also either pure sensory nerves (e.g. cranial nerves 1, 2 & 8) or, are mixed sensory and motor nerves (e.g. cranial nerves, 5, 7, 9 & 10). However, most of the cranial nerves innervate the either above the shoulders, or at shoulder level and the vagus nerve (which contributes to visceral sensation) is the only cranial nerve that innervates organs below the shoulders, at least in humans. Therefore, it has become clear that by far most visceral and somatic sensation in vertebrates, either at a noxious (painful) or innocuous (physiological) level is detected by spinal afferents. Once activated, spinal afferents send sensory information into the spinal cord via the dorsal nerve roots and into the dorsal horn, where they can either make their first synapse and travels up the spinothalamic tract, or travel up the dorsal column, without making a synapse until reaching the brainstem. Either way, lesions to the dorsal nerve roots block all painful and nonpainful sensations.
Although DRG lie just outside the spinal cord and send projections directly into the spinal cord, DRGs are officially recognized as part of the peripheral nervous system. Therefore, it is important to recognize that while the cell bodies of all spinal afferents reside in DRG, they can have very long axons that project long distances (without a synapse) (i.e. >1m) to reach their nerve endings in distal extremities, like the feet or hands. Commonly, spinal afferents and the mechanisms underlying their sensory transduction are studied without neural continuity to their cell bodies in DRG. Hence, it is clear that sensory transduction and the generation of action potentials in spinal afferent nerve endings does not require their nerve cell bodies. In humans, there are 31 pairs of spinal nerves, each with a dorsal and ventral nerve root that are located all along the full length of vertebral column (C1 to S5), remembering that the spinal cord itself stops at L1 vertebrae and does not itself extend all the way down the vertebral column.
It is important to remember that there are also a population of sensory neurons in the wall of the gastrointestinal tract, in the enteric nervous system (11, 31) , that do not require any central or peripheral neural pathways to generate neural reflexes and complex motor patterns in the gastrointestinal tract (26).
Early anterograde tracing techniques developed in vitro to label spinal afferents
Anterograde tracing in vitro was developed in the late 1990's from lesioned extrinsic nerve trunks as they enter isolated segments of intestine (34). This approach has been used to successfully label a class of spinal afferent ending that innervates blood vessels in the small intestine (24), which function as high threshold mechanoreceptors, and also low threshold mechanoreceptors (rectal intraganglionic laminar endings, rIGLEs) in the rectum (4, 14) , including intraganglionic lamellar endings (IGLEs) in the esophagus (35) and stomach (37). In the mouse colon, a class of intramuscular endings have also been identified in the smooth muscle (28) and myenteric ganglia (27). However, it was not possible to be sure whether the nerve endings labeled from extrinsic nerve trunks were spinal afferents, because many other classes of extrinsic efferent and afferent axons were also labeled, such as sympathetic efferents, parasympathetic efferents or possibly collaterals of intestinofugal afferents.
Development of selective anterograde tracing of spinal afferents and their nerve endings
Dorsal root ganglia are easy to isolate from euthanized verterbrates. However, accessing DRG in live animals as a survival surgery is difficult. This is in contrast to nodose and jugular ganglia (that give rise to vagal afferents) which are readily accessible during surgery. DRG are smaller (about 1mm wide in mice) and are difficult to expose in vivo, without substantial blood loss during surgery. We spent many months developing the survival surgery technique, whereby DRGs could be reliably exposed in vivo, then injected with tracers or viruses, as a survival surgery (13) (Fig.1) . Many neuronal tracers were tested. None were as successful at revealing the fine morphological features of nerve endings in visceral organs, except the high molecular weight dextran biotin (13) . Using this tracer, it is now possible to visualize in high resolution (down to single varicosity level) all the different types of nerve endings of only spinal afferents that innervate different visceral organs (13) (Fig.1C) . In the large intestine, we first used this approach to identify all the different types of spinal afferent nerve endings in this region (30) (Fig.1C ). We were mesmerized by unexpectedly complex range of different types of spinal afferent nerve endings that were uncovered by this selective tracing approach. We were most surprised at how many branching axon terminal endings could arise from a single axon. It was not uncommon to identify a single axon entering the large intestine that had >100 axon terminal endings; and these could innervate multiple anatomical layers within the large bowel. In general, at least from our findings in the terminal colorectum, it seemed to suggest that compared to skin, the spinal afferent innervation of viscera (at least the colorectum) appears to have evolved a more extensive and diverse array of sensory endings. All of the endings we identified in the terminal large bowel (30) of course excluded any additional sensory innervation provided by intestinofugal afferents, vagal afferents or intrinsic sensory neurons.
How to correlate the nerve endings arising from a single spinal afferent axon
We found that if many DRGs were injected in the same mouse with dextran biotin, many axons were labeled in the target organ. The problem with this was that many axons typically overlapped each other making it almost impossible to follow the path of single axons and then directly correlate the trajectory of a single axon with its nerve terminal morphology. To get around this problem, we found that by injecting minute quantities of tracer (~50-100nL dextran biotin) into only single DRGs unilaterally, this allowed us to visualize very small numbers of axons in the peripheral organ. This was very exciting, because for the first time in a visceral organ, we could directly visualize the point of entry of single spinal afferent axons into a peripheral organ, then follow their trajectory without ambiguity to their endings, without interference from other axons.
This allowed us to determine: (1) how many endings arise from a single axon and (2) which many anatomical layers are innervated by a single axon. In the terminal colon, we have found that a single axon can innervate 3 different anatomical layers and give off literally hundreds of axon terminals that branch numerous times within the target organ (Fig.2) .
Can transgenic reporter mice be used to identify spinal afferent nerve endings ?
One way to visualize the nerve endings of spinal afferents in peripheral organs, without surgical intervention (and injection of DRG) would be to generate a transgenic mouse that expresses a fluorescent reporter driven by a promoter that is only expressed in DRG neurons. These mice have been generated (10, 17). However, it has been found from our experience that the expression of the reporter is high in the cell bodies of the DRG (sensory neurons), but is considerably weaker in the peripheral terminals. This has precluded detailed characterization of the ultra-fine morphological details of the nerve endings of spinal afferents. Also, any labeled nerve axons or endings cannot be unequivocally confirmed to have originated from DRG sensory neurons, because, as mentioned many sensory peptides are expressed in both DRG and enteric neurons. Indeed, it is known that CGRPα is strongly expressed in DRG, but weakly expressed in enteric neurons of the gastrointestinal tract (10, 18). Using this knowledge, in a previous study, the green fluorescent protein (GFP) was knocked into the CGRPα locus of mice (17). This allowed recordings from the cell bodies of CGRPa expressing nerves in the skin and viscera using ratiometric calcium dyes (Fura-2) (17). Also, recently we generated a transgenic mouse, in which mCherry expression was driven by the CGRPα promoter (10). We generated this mouse so that we could use non-ratiometric calcium indicators (Fluo-4) to record from nerve endings that express CGRPα (25), because GFP fluorescence would overlap with Fluo-4. Using this new mouse, we found that expression of mCherry was high in cell bodies in DRG (10), but weaker in nerve terminals. This precluded identification of the fine structure of spinal afferent endings in visceral organs. Because transgenic expression of mCherry was not able to reveal fine morphological details of single nerve axons, we realized it was necessary to develop a different approach to selectively identify spinal afferent axons in viscera.
Different types of spinal afferent endings in the lower gastrointestinal tract
Following injection of lumbosacral DRGs in live mice, we were astonished to uncover a total of terminal large bowel (30). We were amazed at the complexity of some their endings and how extensively they ramified within different anatomical sites in the large intestine, many with unique morphologies that have not been described previously (Fig.2D) . The greatest number of endings was found in the myenteric ganglia (Fig.2D-F) , submucosa ( Fig.3A & B) and circular muscle, which collectively comprised 82% of all the spinal afferent endings identified in the large bowel.
The fewest number of spinal afferent nerve endings were found in the longitudinal muscle, submucosal ganglia and blood vessels. In our recent unpublished data, the innervation of the colorectum in mice via the thoracolumbar DRGs is considerably less complex than via the lumbosacral DRGs. The spinal afferent innervation of the colorectum from lumbosacral DRGs is of supreme interest to us because from our lesion studies (12), we found that visceral pain from the colorectum is conducted, primarily, if not solely from the lumbosacral DRG pathway under healthy control conditions, and not thoracolumbar DRGs as is often thought.
We were fascinated to find that in myenteric ganglia of the terminal large intestine there were two major classes of spinal afferent endings (30). The most common class was a novel type of ending that has not been described previously that consisted of a single axon that entered a myenteric ganglion, then ramified throughout the ganglion, lacking any complex morphological structure at its terminal ending but consisted of multiple varicosities. We described these endings as intraganglionic varicose endings (IGVEs) (Fig.2D & E) . Of all IGVEs identified, the majority (Fig.2F ), but they were far less common and only comprised 5% of the total proportion of nerve endings identified. rIGLEs have not been identified in the mouse intestine previously, but showed similar morphological features as those described in guinea-pig rectum (14) . That is, they consisted of flattened laminar endings that ramified throughout a single myenteric ganglion. None of the rIGLEs were immunoreactive to CGRP (30), which is consistent with rIGLEs in guinea-pig intestine (14) . Perhaps even more interesting was the observation, that, albeit very rarely, rIGLEs could be identified in submucosal ganglia. The notion that spinal afferent endings actually provide a direct innervation of the gastrointestinal mucosa had not been confirmed until recent anterograde tracing from lumbosacral DRG (30).
Spinal afferent innervation of the upper gastrointestinal tract
Whilst the nerve endings of vagal afferents have been extensively characterized in the esophagus and stomach, following injections of neuronal tracers into nodose and jugular ganglia (1, 2, 20-22), very little was known about spinal afferent endings in the esophagus of mammals (16, 19) and nothing about the stomach of mammals. One previous study injected thoracic DRG of cats and identified nerve fibres in the lower esophagus that ramified around myenteric neurons which were also detected in circular muscle and blood vessels (15, 16). However, unfortunately, the actual nerve endings of these labeled fibres were not resolved. In rats, another study showed that injection of DiI into thoracic DRGs revealed varicose axons in myenteric ganglia of the rat esophagus (19).
Recently, we injected thoracic DRGs in live mice to identify the spinal afferent innervation of the upper GI-tract (29). It was found that there was considerably less complexity in the different types of spinal afferent endings in the stomach compared with the colorectum. A total of 8 different types were identified in full thickness specimens of mouse stomach (29). Because comparatively few DRG neurons innervate the stomach, we found that in order to identify any spinal afferent axons, or endings in the stomach, typically 1 out of every 8 mice would reveal any labelling (29). In the esophagus the success ratio of labelling was even lower with about 1 out of every 10 mice injected (with at least 4 DRGs filled with tracer) revealing any labelled axons. Hence, many mice had to be injected to visualize any endings. In the esophagus, we only found a single major type of ending that consisted of varicose axons in myenteric ganglia (IGVEs) that were very similar to the IGVEs identified in the colorectum (29). The identified IGVE endings in the esophagus we identified in mice were similar to findings from Dr. Neuhubers' group, where anterograde tracing from thoracic DRGs revealed varicose endings in myenteric ganglia of rat esophagus (19).
Spinal afferent endings in the uterus and urinary bladder
Spinal afferent endings are readily labelled in mouse bladder following L6-S3 DRG injections (Fig.4) . Almost all labelled endings are immunoreactive to CGRP. Similar to the findings in the colorectum, single labelled spinal afferent axons that entered the bladder often showed multiple bifurcations, branching numerous times and provided many axon terminal endings. A number of different types of endings have been identified in mouse bladder following lumbosacral DRG injections that predominantly innervating the detrusor muscle. Our work in progress suggests that following thoracolumbar DRG injections a high proportion of the labelled spinal afferent endings innervate the urothelium (See Fig.2B &C) . Spinal afferent axons and endings have been labelled in mouse uterus following thoracolumbar DRG injections (T8-L3). They enter the uterine horns via blood vessels, then branch into the smooth muscle of the myometrium ending as simple-type endings with unspecialized endings (Fig.3C) , all of which to date have been CGRP immunoreactive (Fig.3D) . To date, we have labelled most spinal afferents uterine smooth muscle following thoracolumbar, rather than lumbosacral DRG injections.
New technique to record directly from spinal afferent nerve endings
Until recently, all recordings from spinal afferents have been made from axons or cell bodies outside the peripheral organ they innervate, which is a long way from where sensory transduction takes place. An important step forward is the ability to record the dynamic changes A, Diagrammatic representation of the technique to inject dextran biotin into single DRGs in live mice. Under anesthesia, a midline incision is made to expose DRGs. Glass microelectrodes are used to impale single DRGs and inject small volumes of detran biotin. Because the DRG consist only of the sensory neurons of spinal afferents, the advantage of injecting into these ganglia is that only spinal afferent axons and their endings will be labelled in multiple visceral and somatic organs. This means that none of the efferent (motor) axons exiting the spinal cord will also be labelled. Spinal afferents in the large intestine could technically be labelled from either the lumbar colonic or rectal/pelvic nerve pathways. B, The major pain pathway to the colon is via the rectal/pelvic afferents (in red), whose cell bodies lie in L5-S2 DRG. This was established when lesions to rectal nerves abolished the visceromotor response to colorectal distension, while lesions to the lumbar colonic nerves had no effect on the VMR responses (12) 
